• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腮腺分泌性癌病例系列

Case series of secretory carcinoma in the parotid glands.

作者信息

Wang Shuqin, Peng Yixin, Jiang Cailing, Lin Zicong, Infante-Cossio Pedro, Li Jun

机构信息

Department of Oral and Maxillofacial Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Shenzhen Nanshan Medical Group Headquarter, Shenzhen, China.

出版信息

Gland Surg. 2024 Nov 30;13(11):2198-2205. doi: 10.21037/gs-24-422. Epub 2024 Nov 26.

DOI:10.21037/gs-24-422
PMID:39678404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635574/
Abstract

BACKGROUND

Secretory carcinoma (SC) represents a relatively new and less recognized subtype of salivary gland cancer among clinicians. The objective of our study was to shed light on this rare entity by providing an in-depth analysis of the clinical presentation, pathological characteristics, and treatment outcomes of five patients diagnosed with SC. We also sought to contribute to the understanding of the diagnostic criteria and prognostic factors associated with SC.

CASE DESCRIPTION

The patients, treated at Guangdong Provincial People's Hospital, were aged between 33 and 40 years, with an average age of 33 years. Notably, none of the patients reported pain or noticed a mass initially; however, the mass became progressively larger over time. Diagnostic imaging, such as magnetic resonance imaging (MRI), led to the classification of four cases as benign and one as a low-grade malignancy. We meticulously documented the diagnostic and treatment journey of these patients, including the clinical data, histopathological findings, and subsequent treatment responses.

CONCLUSIONS

Our findings suggest that SC is associated with a favorable prognosis. Nevertheless, the clinical presentation of SC lacks distinct features, necessitating a comprehensive approach that includes immunohistochemistry (IHC) and genetic testing for an accurate diagnosis. This study underscores the importance of recognizing SC as a distinct pathological entity to ensure appropriate patient management and improve outcomes.

摘要

背景

分泌性癌(SC)是临床医生中相对较新且认识较少的涎腺癌亚型。我们研究的目的是通过对5例诊断为SC的患者的临床表现、病理特征和治疗结果进行深入分析,来阐明这种罕见的疾病实体。我们还试图促进对与SC相关的诊断标准和预后因素的理解。

病例描述

在广东省人民医院接受治疗的患者年龄在33岁至40岁之间,平均年龄为33岁。值得注意的是,最初没有患者报告疼痛或发现肿块;然而,随着时间的推移,肿块逐渐变大。磁共振成像(MRI)等诊断性影像学检查将4例分类为良性,1例分类为低级别恶性。我们详细记录了这些患者的诊断和治疗过程,包括临床数据、组织病理学发现及后续治疗反应。

结论

我们的研究结果表明,SC的预后良好。然而,SC的临床表现缺乏明显特征,需要采用包括免疫组织化学(IHC)和基因检测在内的综合方法进行准确诊断。本研究强调了将SC识别为一种独特病理实体对于确保适当的患者管理和改善治疗结果的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/ce451bad9120/gs-13-11-2198-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/182a9746ade1/gs-13-11-2198-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/2a93370f6c86/gs-13-11-2198-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/ce451bad9120/gs-13-11-2198-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/182a9746ade1/gs-13-11-2198-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/2a93370f6c86/gs-13-11-2198-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b97/11635574/ce451bad9120/gs-13-11-2198-f3.jpg

相似文献

1
Case series of secretory carcinoma in the parotid glands.腮腺分泌性癌病例系列
Gland Surg. 2024 Nov 30;13(11):2198-2205. doi: 10.21037/gs-24-422. Epub 2024 Nov 26.
2
Secretory carcinoma of minor salivary glands of buccal mucosa: A case report and review of the literature.颊黏膜小涎腺分泌性癌:一例报告并文献复习
Int J Surg Case Rep. 2023 Jun;107:108357. doi: 10.1016/j.ijscr.2023.108357. Epub 2023 May 26.
3
Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors.伴ETV6-NTRK3基因融合的大、小涎腺分泌性癌:在使用TRK抑制剂的肿瘤非特异性治疗时代克服误诊
Contemp Oncol (Pozn). 2023;27(2):101-108. doi: 10.5114/wo.2023.131204. Epub 2023 Aug 26.
4
Efficacy of Fine-Needle Aspiration Cytology in Diagnosing Secretory Carcinoma of Salivary Gland: A Systematic Review and Meta-Analysis.细针吸取细胞学诊断涎腺分泌性癌的效能:系统评价和荟萃分析。
Acta Cytol. 2024;68(2):83-106. doi: 10.1159/000536249. Epub 2024 Jan 16.
5
Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available.腮腺分泌性癌:在无法进行分子生物学检测时对罕见唾液腺癌做出正确诊断
Case Rep Pathol. 2019 Mar 17;2019:5103496. doi: 10.1155/2019/5103496. eCollection 2019.
6
Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.腮腺的闰管细胞癌和分泌性癌的临床特征。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3461-3466. doi: 10.1007/s00405-019-05604-4. Epub 2019 Aug 22.
7
Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland: Two case reports.来源于口腔小唾液腺的分泌性癌的诊断和治疗:两例报告。
Medicine (Baltimore). 2021 Dec 23;100(51):e28390. doi: 10.1097/MD.0000000000028390.
8
Secretory carcinoma of salivary gland origin: A recently established masquerader.涎腺来源的分泌性癌:一种新近确立的伪装者。
Indian J Cancer. 2021 Apr-Jun;58(2):278-284. doi: 10.4103/ijc.IJC_274_20.
9
Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.唾液腺癌,一种罕见的实体瘤:一项国际多机构研究。
Cancer Cytopathol. 2022 Sep;130(9):684-694. doi: 10.1002/cncy.22574. Epub 2022 Apr 6.
10
A case of metachronous bilateral secretory carcinoma.一例异时性双侧分泌性癌。
Rare Tumors. 2021 Apr 9;13:20363613211009144. doi: 10.1177/20363613211009144. eCollection 2021.

本文引用的文献

1
Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.S100/乳腺珠蛋白/SOX10/DOG1免疫组化表达模式在分泌性癌和腺泡细胞癌鉴别诊断中的应用价值:一项系统评价和Meta分析
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):208-218. doi: 10.1007/s12070-023-04127-z. Epub 2023 Aug 14.
2
Efficacy of Fine-Needle Aspiration Cytology in Diagnosing Secretory Carcinoma of Salivary Gland: A Systematic Review and Meta-Analysis.细针吸取细胞学诊断涎腺分泌性癌的效能:系统评价和荟萃分析。
Acta Cytol. 2024;68(2):83-106. doi: 10.1159/000536249. Epub 2024 Jan 16.
3
Salivary Gland Secretory Carcinoma; Review of 13 Years World-Wide Experience and Meta-Analysis.
涎腺分泌性癌:全球13年经验回顾与荟萃分析
Laryngoscope. 2024 Apr;134(4):1716-1724. doi: 10.1002/lary.31123. Epub 2023 Nov 1.
4
Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis.腮腺乳腺样分泌性癌的预后因素:系统评价与Meta分析
Head Neck. 2022 Mar;44(3):792-804. doi: 10.1002/hed.26971. Epub 2021 Dec 28.
5
Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands.23 例涎腺大唾液腺癌的临床病理特征和转归。
Sci Rep. 2021 Nov 22;11(1):22639. doi: 10.1038/s41598-021-01970-4.
6
NTRK insights: best practices for pathologists.NTRK 解读:病理学家的最佳实践
Mod Pathol. 2022 Mar;35(3):298-305. doi: 10.1038/s41379-021-00913-8. Epub 2021 Sep 16.
7
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for fusion cancers.用于融合癌的小分子原肌球蛋白受体激酶(TRK)抑制剂的研发。
Acta Pharm Sin B. 2021 Feb;11(2):355-372. doi: 10.1016/j.apsb.2020.05.004. Epub 2020 May 23.
8
Identifying patients with NTRK fusion cancer.识别具有 NTRK 融合癌症的患者。
Ann Oncol. 2019 Nov;30 Suppl 8:viii16-viii22. doi: 10.1093/annonc/mdz384. Epub 2019 Dec 24.
9
Outcomes of treatment of mammary analogue secretory carcinoma of the parotid gland.腮腺乳腺样分泌癌的治疗结果。
Br J Oral Maxillofac Surg. 2020 Feb;58(2):158-162. doi: 10.1016/j.bjoms.2019.11.003. Epub 2019 Dec 16.
10
Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.泛 TRK 免疫组化:乳腺分泌性癌的一种有用的辅助诊断方法。
Am J Surg Pathol. 2019 Dec;43(12):1693-1700. doi: 10.1097/PAS.0000000000001366.